JPMorgan Chase & Co. upgraded shares of Varex Imaging (NASDAQ:VREX) from an underweight rating to a neutral rating in a report published on Wednesday, December 20th, Marketbeat.com reports.
Several other research firms have also recently issued reports on VREX. Jefferies Group boosted their target price on Varex Imaging to $39.00 and gave the company a buy rating in a research note on Friday, November 10th. Zacks Investment Research upgraded Varex Imaging from a strong sell rating to a hold rating in a research report on Thursday, October 5th.
Shares of Varex Imaging (NASDAQ VREX) traded up $0.29 during trading on Wednesday, reaching $40.62. The company’s stock had a trading volume of 119,859 shares, compared to its average volume of 141,707. The company has a quick ratio of 1.72, a current ratio of 3.26 and a debt-to-equity ratio of 1.22. The stock has a market cap of $1,550.00 and a PE ratio of 29.87. Varex Imaging has a 1-year low of $25.00 and a 1-year high of $41.99.
In other Varex Imaging news, insider Sunny Sanyal sold 50,000 shares of the business’s stock in a transaction on Thursday, November 16th. The stock was sold at an average price of $36.50, for a total value of $1,825,000.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 1.60% of the company’s stock.
Large investors have recently made changes to their positions in the company. Ameritas Investment Partners Inc. bought a new position in shares of Varex Imaging during the second quarter valued at $112,000. Howard Hughes Medical Institute bought a new position in shares of Varex Imaging during the second quarter valued at $134,000. Oppenheimer Asset Management Inc. bought a new position in shares of Varex Imaging during the second quarter valued at $136,000. Pinebridge Investments L.P. bought a new position in shares of Varex Imaging during the second quarter valued at $167,000. Finally, Tufton Capital Management bought a new position in shares of Varex Imaging during the third quarter valued at $201,000. 92.37% of the stock is currently owned by hedge funds and other institutional investors.
Varex Imaging Company Profile
Varex Imaging Corporation is a supplier of medical X-ray tubes and image processing solutions. The Company’s segments include Medical and Industrial. The X-ray imaging system manufacturers use the Company’s components for medical imaging, cargo screening and border security, to detect, diagnose and protect.
Receive News & Ratings for Varex Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varex Imaging and related companies with MarketBeat.com's FREE daily email newsletter.